Stay updated on Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Sign up to get notified when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.

Latest updates to the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA site-wide NIH notice about terminology during the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.8%

- Check28 days agoChange DetectedThe footer's site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry for v3.7.0 has been added to the history, indicating an update to the study record. The prior revision v3.6.6 entry is removed from the tracked changes.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry, v3.6.6, was added to the study's history and the previous revision, v3.6.5, was removed from the history.SummaryDifference0.1%

- Check84 days agoChange DetectedThe history view now displays Revision: v3.6.5, indicating a new release of the page's UI/version. The previous entry showed Revision: v3.6.4.SummaryDifference0.1%

Stay in the know with updates to Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.